| 查看: 454 | 回复: 0 | |||
[交流]
美国休斯顿卫理公会医院肿瘤中心诚招肿瘤分子生物学博后
|
|
One postdoctoral position is available involved in molecular mechanism research of tumor microenvironment in Dr. Jing Yang’s lab at the Houston Methodist Cancer Center. The candidate will be responsible for the projects to identify new biomarkers or therapeutic targets within the bone marrow microenvironment of multiple myeloma for better prevention, diagnosis, or therapy improvement. The translational research program at Dr. Yang’s lab aims to investigate the interplay between cancer cells and bone marrow stromal cells such as adipocytes, immune cells, and bone cells. And the association between obesity and cancer. These studies explore innovative approaches or strategies to prevent therapeutic resistance and improve chemo and immunotherapeutic efficacy and early detection of hematological malignancies. Please refer to the selected publications from Dr. Yang’s lab for more information (Science Translational Medicine (2016, PMID: 27559096); Science Translational Medicine (2019, PMID: 31142679); Cell Metabolism (2021, PMID: 33406405); Nature Communication (2022, PMID: 35760800). We seek a highly motivated and independent candidate with a recent Ph.D. and/or M.D. degree in one of the following (or relevant) areas: oncology, cancer metabolism, or immunology. A candidate with a strong molecular biology background is preferred. The position is opening now until filled. The pay scale follows the NIH guidelines. Interested applications, including curriculum vitae, a brief cover letter, and the contact information of three references should be sent to Dr.Yang: jyang2@houstonmethodist.org. Jing Yang, PhD Associate professor Houston Methodist Cancer Center Weill Cornell Medical College 6550 Fannin St., SM8-023 Houston, TX 77030 |
» 猜你喜欢
职称评审没过,求安慰
已经有47人回复
26申博自荐
已经有3人回复
回收溶剂求助
已经有7人回复
A期刊撤稿
已经有4人回复
垃圾破二本职称评审标准
已经有17人回复
投稿Elsevier的Neoplasia杂志,到最后选publishing options时页面空白,不能完成投稿
已经有22人回复
EST投稿状态问题
已经有7人回复
毕业后当辅导员了,天天各种学生超烦
已经有4人回复
求助文献
已经有3人回复
三无产品还有机会吗
已经有6人回复













回复此楼